Neonatal conjunctivitis, also known as ophthalmia neonatorum, is one of the causes of severe neonatal morbidity as well as mortality in developing countries.
Neonatal conjunctivitis, also known as ophthalmia neonatorum, is one of the causes of severe neonatal morbidity as well as mortality in developing countries. Neonatal conjunctivitis is defined as conjunctivitis that occurs in newborns mostly during the first few days of life. Clinical signs of the disease include edema, erythema of the eyelids, and purulent discharge from the eyes. Agents of sexually transmitted diseases (STDs) such as Neisseria gonorrhoeae and Chlamydia trachomatis are some of the etiologic agents of neonatal conjunctivitis. Microorganisms that occur on the skin and in the gastrointestinal tract such as Staphylococcus aureus and Pseudomonas sp. can also cause the disease. The cause of neonatal conjunctivitis is difficult to determine.
Read Report Overview - https://www.transparencymarketresearch.com/neonatal-conjunctivitis-treatment-market.html
The global neonatal conjunctivitis treatment market is expect to expand at a significant CAGR during the forecast period. Neonatal conjunctivitis leads to blindness in babies across the world. Rising prevalence of neonatal conjunctivitis in developing countries is one of the factors driving the global market during the forecast period. Surge in the prevalence of sexually transmitted diseases (STDs) is another factor likely to propel the global market during the forecast period. Factors such as poor hygiene conditions, premature deliveries, and maternal sexually transmitted infection are some of the risk factors for neonatal conjunctivitis. Lack of awareness about the treatment of the disease in developing countries and lack of coverage of medicines in these countries are some of the factors restraining the global neonatal conjunctivitis treatment market during the forecast period.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40679
The global neonatal conjunctivitis treatment market can be segmented based on causative agent, distribution channel, and region. Based on causative agent, neonatal conjunctivitis treatment market has been divided into neonatal conjunctivitis caused by Chlamydia, neonatal conjunctivitis caused by Neisseria, neonatal conjunctivitis caused by viruses, and others. The most common cause of neonatal conjunctivitis is Chlamydia. Hence, the neonatal conjunctivitis caused by Chlamydia segment is anticipated to hold a significant share of the global neonatal conjunctivitis treatment market during the forecast period. Based on distribution channel, the global neonatal conjunctivitis treatment market has been divided into hospital pharmacies, drug stores, and online pharmacies. The hospital pharmacies segment is anticipated to the hold the largest share of the global Cellular Therapy in Oncology Pipeline market during the forecast period.
Request for Analysis of COVID-19 Impact on Neonatal Conjunctivitis Treatment Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=40679
Geographically, the global neonatal conjunctivitis treatment market has been divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global market for neonatal conjunctivitis. High prevalence of sexually transmitted diseases (STDs) and rise in awareness about neonatal conjunctivitis are some of the key factors driving neonatal conjunctivitis treatment market in North America. Furthermore, rise in awareness among people about ocular drug delivery systems, rise in per capita health care expenditure, increase in R&D of new drugs are fueling the market in the region. Europe is anticipated to hold the second-largest share of the global neonatal conjunctivitis treatment market from 2017 to 2025, due to rise in the incidence of gonorrhea infection in the region. Neonatal conjunctivitis treatment market in Asia Pacific is anticipated to witness rapid growth during the forecast period. Asia Pacific is a highly lucrative market for neonatal conjunctivitis treatment, due to increase in the prevalence of infections, poor hygiene conditions in developing countries, and prolonged deliveries in some of the countries in the region.
Pre Book Neonatal Conjunctivitis Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=40679<ype=S
In order to acquire a significant position in neonatal conjunctivitis treatment market, key players in the global neonatal conjunctivitis treatment market have adopted strategies such as mergers and acquisitions, improvement in products, and cost-effectiveness. Some of the key players operating in the global neonatal conjunctivitis treatment market are Merck & Co. Inc., Akorn Inc., Pfizer Inc., and Bayer AG.
More Trending Reports by Transparency Market Research:
Monocyte Activation Test Market Increase in the number of pharmaceutical as well as biotechnology companies across the world, rising rate of new drug approvals, and increase in the funding aimed at advancing research and development of new testing technologies are some of the most crucial factors driving the growth in the global monocyte activation test market.
Methicillin-resistant Staphylococcus Aureus Drugs Market The global methicillin-resistant staphylococcus aureus (MRSA) drugs market is estimated to attract notable expansion opportunities in the upcoming years. This growth can be attributed to many factors including increasing occurrence of the antibiotic resistant strains development among population of all age groups.
Healthcare Contract Research Outsourcing Market The global healthcare contract research outsourcing market is expected to expand on the back of many factors such as surge in the efforts intended for costs & drug development time optimization, increase in different services and solutions provided by the CROs, and globalization of clinical trials.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/